Effects of TBE VS GE on Scapular Dyskinesia in Male Cricketers.
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jan 22, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to find out how effective two different types of exercises are for treating scapular dyskinesis, a condition where the shoulder blade moves improperly, in male cricket players. Specifically, the study will compare exercises using a theraband (a stretchy exercise band) versus general exercises. The goal is to see which method helps improve shoulder movement and function better for these athletes.
To participate in this trial, male cricket players aged 18 to 30 who have been playing cricket for at least a year and train regularly (at least four times a week) may be eligible. However, players who have had recent surgeries on their shoulder or neck, or who have certain injuries or serious health issues, won't be able to take part. Since the trial is not yet recruiting, interested players will need to wait for it to start to learn more about how they can get involved. Participants can expect to engage in different exercise routines and help researchers understand what works best for improving shoulder movement in cricketers.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • • Scapular dyskinesia type I
- • Only male cricketers.
- • Age from 18 to 30 years old.
- • Training at least 4 times per week and 10 hours weekly training.
- • Male cricket players playing since last one year.
- Exclusion Criteria:
- • • The history of scapular fracture repair surgery and neck surgery during previous 12 months.
- • The players that are out of practice from 5 weeks.
- • Traumatic history of cervical region and scapula.
- • Serious pathologies regarding shoulder, cervical and scapula.
- • Female cricketers
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Peshawar, Khyber Pkhtunkhwa, Pakistan
Patients applied
Trial Officials
Nadia Ishtiaq, MS
Principal Investigator
nadia.ishtiaq@riphah.edu.pk
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported